What is the Fiscal Year for Harmony Biosciences?
Date: November 13, 2026
Harmony Biosciences's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Plymouth Meeting, PA
Industry
Pharmaceutical Manufacturing
Stock Symbol
HRMY
Description
Harmony Biosciences is a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative therapies for people living with rare and other neurological diseases with unmet medical needs. Guided by empathy, driven by science, and focused on innovation, we combine a strong commercial foundation with a growing pipeline of differentiated programs designed to advance treatment across multiple neurological conditions. By creating long-term value through scientific innovation, operational excellence, and disciplined execution, we invest in our people, our pipeline, and our mission to help improve patients’ lives. Follow us: Instagram → @harmony_biosciences X → @harmonybio #InHarmony #EmpathyAndInnovation View community guidelines: http://bit.ly/4v2Exc8
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Harmony Biosciences and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.